P2Y12 receptor inhibitors in patients with non-ST

Comments

Transcription

P2Y12 receptor inhibitors in patients with non-ST
From: P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world:
use, patient selection, and outcomes from contemporary European registries
Eur Heart J Cardiovasc Pharmacother. 2016;2(4):229-243. doi:10.1093/ehjcvp/pvw005
Eur Heart J Cardiovasc Pharmacother | Published on behalf of the European Society of Cardiology. All rights reserved. © The
Author 2016. For permissions please email: [email protected]
From: P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world:
use, patient selection, and outcomes from contemporary European registries
Eur Heart J Cardiovasc Pharmacother. 2016;2(4):229-243. doi:10.1093/ehjcvp/pvw005
Eur Heart J Cardiovasc Pharmacother | Published on behalf of the European Society of Cardiology. All rights reserved. © The
Author 2016. For permissions please email: [email protected]
From: P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world:
use, patient selection, and outcomes from contemporary European registries
Eur Heart J Cardiovasc Pharmacother. 2016;2(4):229-243. doi:10.1093/ehjcvp/pvw005
Eur Heart J Cardiovasc Pharmacother | Published on behalf of the European Society of Cardiology. All rights reserved. © The
Author 2016. For permissions please email: [email protected]

Similar documents